<oai:record xmlns:dri="http://www.driver-repository.eu/namespace/dri" xmlns="http://namespace.openaire.eu/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dr="http://www.driver-repository.eu/namespace/dr" xmlns:oaf="http://namespace.openaire.eu/oaf" xmlns:prov="http://www.openarchives.org/OAI/2.0/provenance">
<oai:header><dri:objIdentifier>od_______267::2a0cd8975b85a46f8d52d6521f9adde6</dri:objIdentifier><dri:recordIdentifier>oai:pubmedcentral.nih.gov:4219982</dri:recordIdentifier><dri:dateOfCollection>2018-06-11T22:13:09.769Z</dri:dateOfCollection><oaf:datasourceprefix>od_______267</oaf:datasourceprefix><identifier xmlns="http://www.openarchives.org/OAI/2.0/">oai:pubmedcentral.nih.gov:4219982</identifier><datestamp xmlns="http://www.openarchives.org/OAI/2.0/">2014-11-06</datestamp><setSpec xmlns="http://www.openarchives.org/OAI/2.0/">bmfh</setSpec><setSpec xmlns="http://www.openarchives.org/OAI/2.0/">pmc-open</setSpec></oai:header>
<metadata xmlns="http://www.openarchives.org/OAI/2.0/">
<article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biosci Microbiota Food Health</journal-id>
      <journal-id journal-id-type="iso-abbrev">Biosci Microbiota Food Health</journal-id>
      <journal-id journal-id-type="publisher-id">BMFH</journal-id>
      <journal-title-group>
        <journal-title>Bioscience of Microbiota, Food and Health</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2186-6953</issn>
      <issn pub-type="epub">2186-3342</issn>
      <publisher>
        <publisher-name>BMFH Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4219982</article-id>
      <article-id pub-id-type="pmcid">PMC4219982</article-id>
      <article-id pub-id-type="pmc-uid">4219982</article-id>
      <article-id pub-id-type="pmid">25379363</article-id>
      <article-id pub-id-type="publisher-id">2014-004</article-id>
      <article-id pub-id-type="doi">10.12938/bmfh.33.157</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Full Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Lactobacillus acidophilus</italic> L-92 Cells Activate Expression of Immunomodulatory Genes in THP-1
Cells</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>YANAGIHARA</surname>
            <given-names>Sae</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>GOTO</surname>
            <given-names>Hiroaki</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>HIROTA</surname>
            <given-names>Tatsuhiko</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>FUKUDA</surname>
            <given-names>Shinji</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>OHNO</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>YAMAMOTO</surname>
            <given-names>Naoyuki</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
          <xref rid="cor1" ref-type="corresp">
            <sup>*</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1</label>Microbiology and Fermentation Laboratory, Calpis Co. Ltd., 5–11–10 Fuchinobe, Chuo-ku,
Sagamihara-shi, Kanagawa 252-0206, Japan</aff>
        <aff id="aff2"><label>2</label>Intestinal Microbe Symbiosis Laboratory, RIKEN, Wako, Saitama 351-0198, Japan</aff>
        <aff id="aff3"><label>3</label>Laboratory for Intestinal Ecosystem, RCAI, RIKEN Center for Integrative Medical Sciences, Yokohama,
Kanagawa 230-0045, Japan</aff>
        <aff id="aff4"><label>4</label>Immunobiology Laboratory, Graduate School of Medical Life Science, Yokohama City University,
Yokohama, Kanagawa 230-0045, Japan</aff>
        <aff id="aff5"><label>5</label>Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata 997-0052, Japan</aff>
        <aff id="aff6"><label>6</label>Research and Development Planning Department, Calpis Co. Ltd., 5–11–10 Fuchinobe, Chuo-ku,
Sagamihara-shi, Kanagawa 252-0206, Japan</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">*Corresponding author. Mailing address: Naoyuki Yamamoto, Research and Development Planning Department, Calpis
Co. Ltd., 5–11–10 Fuchinobe, Chuo-ku, Sagamihara-shi, Kanagawa 252-0206, Japan. Phone: +81-42-769-7811, Fax: +81-42-769-7842.
E-mail: <email xlink:href="naoyuki.yamamoto@calpis.co.jp">naoyuki.yamamoto@calpis.co.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>8</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2014</year>
      </pub-date>
      <volume>33</volume>
      <issue>4</issue>
      <fpage>157</fpage>
      <lpage>164</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>03</day>
          <month>7</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>©2014 BMFH Press</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No
Derivatives (by-nc-nd) License. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>To understand the immunomodulatory effects of <italic>Lactobacillus acidophilus</italic> L-92 cells suggested from our previous
study of <italic>in vivo</italic> anti-allergy and anti-virus effects, host immune responses in macrophage-like THP-1 cells after
4 h (the early phase) and 24 h (the late phase) of cocultivation with L-92 cells were investigated by transcriptome analysis. In
the early phase of L-92 treatment, various transcription regulator genes, such as, <italic>NFkB1, NFkB2, JUN, HIVEP2</italic> and
<italic>RELB,</italic> and genes encoding chemokines and cytokines, such as <italic>CCL4, CXCL11, CCL3</italic> and
<italic>TNF,</italic> were upregulated. Two transmembrane receptor genes, <italic>TLR7</italic> and <italic>ICAM1</italic>, were
also upregulated in the early phase of treatment. In contrast, many transmembrane receptor genes, such as <italic>IL7R, CD80,
CRLF2, CD86, CD5, HLA-DQA1, IL2RA, IL15RA</italic> and <italic>CSF2RA</italic>, and some cytokine genes, including <italic>IL6,
IL23A</italic> and <italic>CCL22</italic>, were significantly upregulated in the late phase after L-92 exposure. Some genes
encoding cytokines, such as <italic>IL1A, IL1B</italic> and <italic>IL8,</italic> and the enzyme <italic>IDO1</italic> were
upregulated at both the early and the late phases of treatment. These results suggest that probiotic L-92 might promote Th1 and
regulatory T-cell responses by activation of the MAPK signaling pathway, followed by the NOD-like receptor signaling pathway in
THP-1 cells.</p>
      </abstract>
      <kwd-group>
        <kwd><italic>Lactobacillus acidophilus</italic> L-92</kwd>
        <kwd>transcriptome analysis</kwd>
        <kwd>transcription regulator</kwd>
        <kwd>cytokine</kwd>
        <kwd>THP-1</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>INTRODUCTION</title>
      <p>A variety of lactic acid bacteria (LAB) have been isolated and used in mainly dairy foods and supplements for their health benefits
in humans. One of the most important probiotic effects of LAB in a host would be its action on the gastrointestinal immune system,
which may be beneficial in the prevention of gastrointestinal infections [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r2" ref-type="bibr">2</xref>], and inflammatory bowel diseases [<xref rid="r3" ref-type="bibr">3</xref>] and the alleviation
of allergic diseases [<xref rid="r4" ref-type="bibr">4</xref>]. Among many probiotic strains that have been developed,
<italic>Lactobacillus</italic> strains have been characterized as strong inducers of pro-inflammatory cytokines, such as IL-12 and
tumor necrosis factor (TNF-α) [<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r6" ref-type="bibr">6</xref>], and they seem to
be different from the weak IL-12 inducer bifidobacteria.</p>
      <p><italic>Lactobacillus acidophilus</italic> L-92 has been developed as a strain with anti-allergy effects for pollen allergy [<xref rid="r7" ref-type="bibr">7</xref>], perennial allergy [<xref rid="r8" ref-type="bibr">8</xref>], and atopic dermatitis [<xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r10" ref-type="bibr">10</xref>], and it also has the ability to control
gastrointestinal disorders [<xref rid="r11" ref-type="bibr">11</xref>]. To explain these <italic>in vivo</italic> anti-allergy
effects, various mechanisms have been proposed, including an improvement in the balance of T helper 1 (Th1) cells and T helper 2
(Th2) cells, induction of apoptosis, induction or activation of regulatory T cells, and activation of the innate immune system
[<xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r14" ref-type="bibr">14</xref>]. Our recent study demonstrated that surface layer protein A (SlpA) on the
cell wall of the <italic>L. acidophilus</italic> L-92 strain is important for enhancement of the release of IL-12, known as a
Th1-type cytokine, from splenocytes [<xref rid="r15" ref-type="bibr">15</xref>]. However, the detailed mechanisms of such immune
modulation events are unknown.</p>
      <p>The Peyer’s patch, lamina propria and mesenteric lymph nodes of the gastrointestinal tract play a crucial role in controlling the
gastrointestinal immune system. In the gastrointestinal immune system, contact between LAB and antigen-presenting cells (APCs), such
as dendritic cells (DCs) and macrophages, is likely to be a particularly important process for initiation of host immune responses
by priming innate and adaptive immunity [<xref rid="r16" ref-type="bibr">16</xref>]. Probiotic microbial signals are thought to be
transmitted to DCs via Toll-like receptors [<xref rid="r17" ref-type="bibr">17</xref>]; however, few reports have addressed the
action of probiotics on cells of the immune system. To improve understanding of the events in DCs, transcriptome analyses have been
conducted both in animal studies and in human trials [<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref>]. Macrophage-like THP-1 cells represent a well responding and physiologically
meaningful model system for investigation of the context of innate immunity.</p>
      <p>We herein report a detailed analysis of cell metabolism of macrophages in response to L-92 by using transcriptomic analysis on
THP-1 cells, which show a response to L-92 cells similar to that of splenocytes by releasing IL-12. The present study suggests that
probiotic L-92 might activate Th1 and regulatory T-cell responses by engaging the MAPK and NOD-like receptor signaling pathways.</p>
    </sec>
    <sec sec-type="materials|methods" id="s2">
      <title>MATERIALS AND METHODS</title>
      <sec>
        <title>THP-1 cell culture</title>
        <p>The human monocyte cell line THP-1 [<xref rid="r21" ref-type="bibr">21</xref>, <xref rid="r22" ref-type="bibr">22</xref>] was
obtained from the Health Science Research Resources Bank (Tokyo, Japan) and maintained in RPMI-1640 (Sigma, St. Louis, MO, USA)
containing 10% (V/V) of heat-inactivated fetal bovine serum (FBS; Hana-Nesco Bio, Tokyo, Japan), streptomycin (100 µg/ml) and
penicillin (100 U/ml) (GIBCO, Grand Island, NY, USA) at 37°C in 5% CO<sub>2</sub>/95% air.</p>
      </sec>
      <sec>
        <title>Preparation of heat-killed L-92 cells</title>
        <p><italic>Lactobacillus acidophilus</italic> L-92 from our stock culture collection was cultured anaerobically at 37°C for 20 hr in
de Man, Rogosa and Sharpe (MRS) broth (Difco Laboratories, Detroit, MI, USA), and washed with phosphate-buffered saline (PBS).
Bacteria were suspended in PBS and killed by heating at 100°C for 10 min.</p>
      </sec>
      <sec>
        <title>L-92 treatment of THP-1 cells</title>
        <p>For transcriptome analysis of THP-1 metabolism, THP-1 cells were grown in RPMI-1640 containing 10% (V/V) of heat-inactivated FBS,
streptomycin (100 µg/ml) and penicillin (100 U/ml) in a 250 mL flask (Sumitomo Bakelite Co., Ltd., Tokyo, Japan) at 37°C in 5%
CO<sub>2</sub>/95% air and stimulated to macrophage-like cells by a method described previously, with some modifications [<xref rid="r23" ref-type="bibr">23</xref>]. Briefly, THP-1 cells were suspended in 2 mL of RPMI-1640 at a cell density of 5 ×
10<sup>6</sup> cells/ml and cultivated in a 6-well plate (Asahi Glass Co., Ltd., Tokyo, Japan). The cells were differentiated by
cultivation in 1.2% (V/V) Me<sub>2</sub>SO containing RPMI-1640 for 24 hr and stimulated with IFN-γ (5000 U/ml) for 16 hr.
Unstained cells were counted as viable cell after treatment with Trypan Blue Solution (0.4%) (Sigma, St. Louis, MO, USA). Next, 1
× 10<sup>9</sup> cells of heat-killed L-92, suspended in 0.2 mL of culture buffer, were added to stimulate the THP-1 cells. The
THP-1 cells were then harvested after 4 and 24 hr of cocultivation with L-92 in the culture medium. The THP-1 cells were collected
by centrifugation at 4°C for 10 min at 430 × <italic>g</italic>, and cell pellets were washed twice with cold D-PBS (Sigma) for
total RNA extraction. Cells untreated with L-92 cells and stimulated with IFN-γ (5000 U/ml) for 16 hr were used as controls. Three
samples were prepared from three independent experiments for each group.</p>
      </sec>
      <sec>
        <title>Microarray analysis</title>
        <p>Total RNA was extracted by using an RNeasy Mini Kit (QIAGEN, Valencia, CA, USA). Double-stranded cDNA was synthesized from 5 µg
of total RNA, and the cDNA was subjected to <italic>in vitro</italic> transcription in the presence of biotinylated nucleotide
triphosphates. Human genome-wide gene expression was examined by using the GeneChip<sup>®</sup> Human Gene 1.0 ST Array
(Affymetrix, Santa Clara, CA, USA), which contains oligonucleotide probe sets for approximately 28,869 full-length genes and
expressed sequence tags. The biotinylated cDNA was hybridized with a probe array for 16 hr at 45°C. The hybridized products were
stained with streptavidin-phycoerythrin, and then scanned with a Hewlett-Packard Gene Array Scanner (Palo Alto, CA, USA). The
fluorescence intensity of each probe was quantified by using the GeneChip Analysis Suite 5.0 software (Affymetrix). The level of
gene expression was determined as the average difference by using the GeneChip software.</p>
      </sec>
      <sec>
        <title>Statistical and functional analysis of microarray data</title>
        <p>Data analysis was performed with GeneSpring software version 6.1 (Silicon Genetics, San Carlos, CA, USA). Expression data were
considered significant when they differed at least twofold between L-92-treated and PBS-treated cells, and were statistically
analyzed by the unpaired t-test with the Benjamini-Hochberg post test. P-values of less than 0.05 were considered significant.
Biological interaction networks among regulated genes activated in response to L-92 were identified using Ingenuity Pathways
Analysis (IPA). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was used for deeper understanding of the
metabolism of the altered gene expression.</p>
      </sec>
      <sec>
        <title>Quantitative real-time (qRT)-PCR</title>
        <p>A two-step RT-PCR reaction was employed. cDNA was synthesized according to the protocol of the Superscript III First-Strand cDNA
Synthesis System (Invitrogen, Carlsbad, CA, USA) using 1 µg of total RNA. cDNA was diluted, and frozen aliquots were stored at
−20°C. The cDNA generated was amplified using SYBR<sup>®</sup> Premix Ex Taq<sup>TM</sup> II (Tli RNaseH Plus) (Takara Bio, Inc.,
Shiga, Japan). All assays were performed on a TP800 Thermal Cycler Dice<sup>®</sup> Real Time System (Takara Bio, Inc.). Primers
were prepared for amplification of specific genes, TNF, CRLF2, GAPDH, CD86, STAT4 and IL-8 genes. The sequences of the primers
(forward and reverse primers) used in PCR reactions were 5′-AGATGATCTGACTGCCTGGG-3′ and 5′-CTGCTGCACTTTGGAGTGAT-3′ for TNF,
5′-CTGATGCCACGAAAATCTCA-3′ and 5′-TTCTCCATCAGGAATGGGAC-3′ for CRLF25’, 5′-GCACCGTCAAGGCTGAGAAC-3′ and 5′-TGGTGAAGACGCCAGTGGA -3′
for GAPDH, 5′-AGAGGAGCAGCACCAGAGAG-3′ and 5′-CAGAAGCAGCCAAAATGGAT-3′ for CD86, 5′-CACAGCTACATGCATTGGATT-3′and
5′-CGTGTTTCCAAAGAGAAAAACC-3′ for STAT4 and 5′-CTGGCCGTGGCTCTCTTG-3′ and 5′-CCTTGGCAAAACTGCACCTT-3′ for and IL8. A cycle threshold
(Ct) was assigned at the beginning of the logarithmic phase of PCR amplification. Data were analyzed by ABI software, and the gene
expression was quantified using the 2<sup>−ΔΔCT</sup> method and normalized to the constitutively expressed housekeeping gene
<italic>GAPDH</italic>.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="s3">
      <title>RESULTS</title>
      <sec>
        <title>Altered gene pathways in THP-1 cells</title>
        <p>To understand the host immunomodulatory effects of <italic>L. acidophilus</italic> L-92 cells suggested from previous studies of
<italic>in vivo</italic> anti-allergy and anti-virus effects, responses in THP-1 cells after 4 hr (the early phase) and 24 hr
(the late phase) of cocultivation with L-92 cells were investigated by transcriptome analysis. For cultivation of THP-1 cells in
RPMI-1640 medium, a high concentration of IFN-γ was added to enhance IL-12 release for the Th1 type cell response based on our
previous study. Viability of the THP-1 cells after inoculation in RPMI-1640 medium with IFN-γ at 16 hr was 96.3%. Differential
expression analysis showed a significant (more than 2-fold) up- or downregulation of 282 genes in the early phase and 2,411 genes
in the late phase in THP-1 cells caused by treatment with L-92 (data not shown).</p>
        <p>Next, IPA was used to integrate the transcriptional networks for a more detailed understanding of the main networks linked to
immunomodulatory responses in THP-1 cells, as described in the Materials and Methods. In the IPA analysis, the most significant
differences in biological functions, referred to as “hematological process”, were found after 4 hr (66 molecules; p=1.34 ×
10<sup>−28</sup>) and 24 hr (253 molecules; p=1.42 × 10<sup>−37</sup>) of treatment with L-92 cells. At the early phase of the
treatment (4 hr), transcription regulators, cytokines and transmembrane receptors in particular showed highly altered expression
(<xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title> Ingenuity pathway analysis for altered gene expression in THP-1 cells treated with heat-killed <italic>Lactobacillus
acidophilus</italic> L-92 cells</title></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" rowspan="1" colspan="1">Category</td><td align="center" rowspan="1" colspan="1">4 hr</td><td align="center" rowspan="1" colspan="1">24 hr</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Transcription regulator</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">53</td></tr><tr><td align="left" rowspan="1" colspan="1">Enzyme</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">31</td></tr><tr><td align="left" rowspan="1" colspan="1">Transmembrane receptor</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">28</td></tr><tr><td align="left" rowspan="1" colspan="1">Cytokine</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">24</td></tr><tr><td align="left" rowspan="1" colspan="1">Kinase</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1">G-protein coupled receptor</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">Phosphatase</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">Growth factor</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">Peptidase</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">Ion channel</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Ligand-dependent nuclear receptor</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Transporter</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Other</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">62</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">253</td></tr></tbody></table></table-wrap>). In the late phase of the treatment with L-92, transcription regulators, enzymes, transmembrane receptors and
cytokines were mostly upregulated (<xref rid="tbl_001" ref-type="table">Table 1</xref>). Over the course of the treatment, the
majority of genes with altered expression were transcription regulators, enzymes, cytokines and transmembrane receptors (<xref rid="tbl_001" ref-type="table">Table 1</xref>). These results revealed that the genes showing changes in expression in THP-1
cells caused by L-92 treatment were mainly associated with immune response and transcriptional regulation.</p>
      </sec>
      <sec>
        <title>Altered genes in THP-1 cells</title>
        <p>For a deeper understanding of each cellular response in THP-1 cells caused by L-92 treatment, genes that showed significant
changes, especially those in the transcription regulator, enzyme, transmembrane receptor and cytokine categories that showed over
a 4-fold change after 4 hr of treatment and less than a 4-fold change from 4 hr to 24 hr of L-92 treatment, are listed in <xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title> Major altered genes categorized as transcription regulators, enzymes, transmembrane receptors and cytokines in THP-1
cells after L-92 treatment for 4 hr and 24 hr</title></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" rowspan="2" colspan="1">Category</td><td align="center" rowspan="2" colspan="1">Entrez Gene Name</td><td align="center" rowspan="2" colspan="1">Symbol</td><td align="center" colspan="2" rowspan="1">Fold change<hr/></td></tr><tr><td align="center" rowspan="1" colspan="1">0–4 hr</td><td align="center" rowspan="1" colspan="1">4–24 hr</td></tr></thead><tbody><tr><td align="left" colspan="3" rowspan="1">Early responding genes</td><td align="center" rowspan="1" colspan="1">&gt; 4.0</td><td align="center" rowspan="1" colspan="1">4.0 &gt;</td></tr><tr><td align="left" colspan="5" rowspan="1"> Cytokine</td></tr><tr><td align="left" rowspan="5" colspan="1"/><td align="left" rowspan="1" colspan="1">chemokine (C-C motif) ligand 4</td><td align="left" rowspan="1" colspan="1"><italic>CCL4</italic></td><td align="center" rowspan="1" colspan="1">58.29 </td><td align="center" rowspan="1" colspan="1">2.02 </td></tr><tr><td align="left" rowspan="1" colspan="1">chemokine (C-X-C motif) ligand 11</td><td align="left" rowspan="1" colspan="1"><italic>CXCL11</italic></td><td align="center" rowspan="1" colspan="1">27.97 </td><td align="center" rowspan="1" colspan="1">2.28 </td></tr><tr><td align="left" rowspan="1" colspan="1">chemokine (C-C motif) ligand 3</td><td align="left" rowspan="1" colspan="1"><italic>CCL3</italic></td><td align="center" rowspan="1" colspan="1">20.04 </td><td align="center" rowspan="1" colspan="1">2.77 </td></tr><tr><td align="left" rowspan="1" colspan="1">tumor necrosis factor</td><td align="left" rowspan="1" colspan="1"><italic>TNF</italic></td><td align="center" rowspan="1" colspan="1">14.57 </td><td align="center" rowspan="1" colspan="1">1.15 </td></tr><tr><td align="left" rowspan="1" colspan="1">interleukin 1 receptor antagonist</td><td align="left" rowspan="1" colspan="1"><italic>IL1RN</italic></td><td align="center" rowspan="1" colspan="1">5.11 </td><td align="center" rowspan="1" colspan="1">1.95 </td></tr><tr><td align="left" colspan="5" rowspan="1"> Transmembrane receptor</td></tr><tr><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="1" colspan="1">intercellular adhesion molecule 1</td><td align="left" rowspan="1" colspan="1"><italic>ICAM1</italic></td><td align="center" rowspan="1" colspan="1">10.01 </td><td align="center" rowspan="1" colspan="1">2.33 </td></tr><tr><td align="left" rowspan="1" colspan="1">toll-like receptor 7</td><td align="left" rowspan="1" colspan="1"><italic>TLR7</italic></td><td align="center" rowspan="1" colspan="1">6.63 </td><td align="center" rowspan="1" colspan="1">0.32 </td></tr><tr><td align="left" colspan="5" rowspan="1"> Enzyme</td></tr><tr><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="1" colspan="1">superoxide dismutase 2, mitochondrial</td><td align="left" rowspan="1" colspan="1"><italic>SOD2</italic></td><td align="center" rowspan="1" colspan="1">10.04 </td><td align="center" rowspan="1" colspan="1">2.50 </td></tr><tr><td align="left" rowspan="1" colspan="1">heme oxygenase (decycling) 1</td><td align="left" rowspan="1" colspan="1"><italic>HMOX1</italic></td><td align="center" rowspan="1" colspan="1">4.26 </td><td align="center" rowspan="1" colspan="1">2.21 </td></tr><tr><td align="left" colspan="5" rowspan="1"> Transcription regulator</td></tr><tr><td align="left" rowspan="5" colspan="1"/><td align="left" rowspan="1" colspan="1">jun proto-oncogene</td><td align="left" rowspan="1" colspan="1"><italic>JUN</italic></td><td align="center" rowspan="1" colspan="1">4.99 </td><td align="center" rowspan="1" colspan="1">2.72 </td></tr><tr><td align="left" rowspan="1" colspan="1">nuclear factor of kappa light polypeptide gene enhancer in B-cells 1</td><td align="left" rowspan="1" colspan="1"><italic>NFKB1</italic></td><td align="center" rowspan="1" colspan="1">5.18 </td><td align="center" rowspan="1" colspan="1">2.21 </td></tr><tr><td align="left" rowspan="1" colspan="1">nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)</td><td align="left" rowspan="1" colspan="1"><italic>NFKB2</italic></td><td align="center" rowspan="1" colspan="1">6.10 </td><td align="center" rowspan="1" colspan="1">1.85 </td></tr><tr><td align="left" rowspan="1" colspan="1">human immunodeficiency virus type I enhancer binding protein 2</td><td align="left" rowspan="1" colspan="1"><italic>HIVEP2</italic></td><td align="center" rowspan="1" colspan="1">4.18 </td><td align="center" rowspan="1" colspan="1">2.29 </td></tr><tr><td align="left" rowspan="1" colspan="1">v-rel reticuloendotheliosis viral oncogene homolog B</td><td align="left" rowspan="1" colspan="1"><italic>RELB</italic></td><td align="center" rowspan="1" colspan="1">4.34 </td><td align="center" rowspan="1" colspan="1">1.04 </td></tr><tr><td align="left" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" colspan="3" rowspan="1">Slowly responding genes</td><td align="center" rowspan="1" colspan="1">0–4 hr</td><td align="center" rowspan="1" colspan="1">4–24 hr</td></tr><tr><td align="left" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" colspan="3" rowspan="1"> Transmembrane receptor</td><td align="center" rowspan="1" colspan="1">4.0 &gt;</td><td align="center" rowspan="1" colspan="1">&gt; 4.0</td></tr><tr><td align="left" rowspan="9" colspan="1"/><td align="left" rowspan="1" colspan="1">interleukin 7 receptor</td><td align="left" rowspan="1" colspan="1"><italic>IL7R</italic></td><td align="center" rowspan="1" colspan="1">1.83 </td><td align="center" rowspan="1" colspan="1">63.99 </td></tr><tr><td align="left" rowspan="1" colspan="1">CD80 molecule</td><td align="left" rowspan="1" colspan="1"><italic>CD80</italic></td><td align="center" rowspan="1" colspan="1">1.74 </td><td align="center" rowspan="1" colspan="1">61.40 </td></tr><tr><td align="left" rowspan="1" colspan="1">cytokine receptor-like factor 2</td><td align="left" rowspan="1" colspan="1"><italic>CRLF2</italic></td><td align="center" rowspan="1" colspan="1">2.02 </td><td align="center" rowspan="1" colspan="1">52.00 </td></tr><tr><td align="left" rowspan="1" colspan="1">CD86 molecule</td><td align="left" rowspan="1" colspan="1"><italic>CD86</italic></td><td align="center" rowspan="1" colspan="1">0.86 </td><td align="center" rowspan="1" colspan="1">30.10 </td></tr><tr><td align="left" rowspan="1" colspan="1">CD5 molecule</td><td align="left" rowspan="1" colspan="1"><italic>CD5</italic></td><td align="center" rowspan="1" colspan="1">1.10 </td><td align="center" rowspan="1" colspan="1">16.20 </td></tr><tr><td align="left" rowspan="1" colspan="1">interleukin 15 receptor, alpha</td><td align="left" rowspan="1" colspan="1"><italic>IL15RA</italic></td><td align="center" rowspan="1" colspan="1">2.06 </td><td align="center" rowspan="1" colspan="1">4.37 </td></tr><tr><td align="left" rowspan="1" colspan="1">major histocompatibility complex, class II, DQ alpha 1</td><td align="left" rowspan="1" colspan="1"><italic>HLA-DQA1</italic></td><td align="center" rowspan="1" colspan="1">0.94 </td><td align="center" rowspan="1" colspan="1">5.93 </td></tr><tr><td align="left" rowspan="1" colspan="1">interleukin 2 receptor, alpha</td><td align="left" rowspan="1" colspan="1"><italic>IL2RA</italic></td><td align="center" rowspan="1" colspan="1">1.00 </td><td align="center" rowspan="1" colspan="1">4.98 </td></tr><tr><td align="left" rowspan="1" colspan="1">colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)</td><td align="left" rowspan="1" colspan="1"><italic>CSF2RA</italic></td><td align="center" rowspan="1" colspan="1">0.85 </td><td align="center" rowspan="1" colspan="1">4.15 </td></tr><tr><td align="left" colspan="5" rowspan="1"> Cytokine</td></tr><tr><td align="left" rowspan="6" colspan="1"/><td align="left" rowspan="1" colspan="1">interleukin 12B (natural killer cell stimulatory factor 2, p40)</td><td align="left" rowspan="1" colspan="1"><italic>IL12B</italic></td><td align="center" rowspan="1" colspan="1">3.39 </td><td align="center" rowspan="1" colspan="1">18.10 </td></tr><tr><td align="left" rowspan="1" colspan="1">interleukin 6 (interferon, beta 2)</td><td align="left" rowspan="1" colspan="1"><italic>IL6</italic></td><td align="center" rowspan="1" colspan="1">1.08 </td><td align="center" rowspan="1" colspan="1">54.45 </td></tr><tr><td align="left" rowspan="1" colspan="1">interleukin 23, alpha subunit p19</td><td align="left" rowspan="1" colspan="1"><italic>IL23A</italic></td><td align="center" rowspan="1" colspan="1">1.29 </td><td align="center" rowspan="1" colspan="1">28.01 </td></tr><tr><td align="left" rowspan="1" colspan="1">secreted phosphoprotein 1</td><td align="left" rowspan="1" colspan="1"><italic>SPP1 </italic></td><td align="center" rowspan="1" colspan="1">2.73 </td><td align="center" rowspan="1" colspan="1">11.06 </td></tr><tr><td align="left" rowspan="1" colspan="1">chemokine (C-C motif) ligand 22</td><td align="left" rowspan="1" colspan="1"><italic>CCL22</italic></td><td align="center" rowspan="1" colspan="1">1.07 </td><td align="center" rowspan="1" colspan="1">17.16 </td></tr><tr><td align="left" rowspan="1" colspan="1">chemokine (C-C motif) ligand 19</td><td align="left" rowspan="1" colspan="1"><italic>CCL19</italic></td><td align="center" rowspan="1" colspan="1">1.13 </td><td align="center" rowspan="1" colspan="1">9.65 </td></tr><tr><td align="left" colspan="5" rowspan="1"> Transcription regulator</td></tr><tr><td align="left" rowspan="6" colspan="1"/><td align="left" rowspan="1" colspan="1">early B-cell factor 1</td><td align="left" rowspan="1" colspan="1"><italic>EBF1</italic></td><td align="center" rowspan="1" colspan="1">1.12 </td><td align="center" rowspan="1" colspan="1">41.89 </td></tr><tr><td align="left" rowspan="1" colspan="1">signal transducer and activator of transcription 4</td><td align="left" rowspan="1" colspan="1"><italic>STAT4</italic></td><td align="center" rowspan="1" colspan="1">1.42 </td><td align="center" rowspan="1" colspan="1">23.28 </td></tr><tr><td align="left" rowspan="1" colspan="1">runt-related transcription factor 1; translocated to, 1 (cyclin D-related)</td><td align="left" rowspan="1" colspan="1"><italic>RUNX1T1</italic></td><td align="center" rowspan="1" colspan="1">0.97 </td><td align="center" rowspan="1" colspan="1">8.18 </td></tr><tr><td align="left" rowspan="1" colspan="1">zinc finger protein, multitype 2</td><td align="left" rowspan="1" colspan="1"><italic>ZFPM2</italic></td><td align="center" rowspan="1" colspan="1">1.05 </td><td align="center" rowspan="1" colspan="1">5.65 </td></tr><tr><td align="left" rowspan="1" colspan="1">B-cell CLL/lymphoma 11A (zinc finger protein)</td><td align="left" rowspan="1" colspan="1"><italic>BCL11A</italic></td><td align="center" rowspan="1" colspan="1">0.85 </td><td align="center" rowspan="1" colspan="1">6.92 </td></tr><tr><td align="left" rowspan="1" colspan="1">growth factor independent 1 transcription repressor</td><td align="left" rowspan="1" colspan="1"><italic>GFI1</italic></td><td align="center" rowspan="1" colspan="1">–2.21 </td><td align="center" rowspan="1" colspan="1">–5.00 </td></tr><tr><td align="left" colspan="5" rowspan="1"> Enzyme</td></tr><tr><td align="left" rowspan="6" colspan="1"/><td align="left" rowspan="1" colspan="1">prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)</td><td align="left" rowspan="1" colspan="1"><italic>PTGS2</italic></td><td align="center" rowspan="1" colspan="1">2.58 </td><td align="center" rowspan="1" colspan="1">14.29 </td></tr><tr><td align="left" rowspan="1" colspan="1">adenosine deaminase</td><td align="left" rowspan="1" colspan="1"><italic>ADA</italic></td><td align="center" rowspan="1" colspan="1">1.07 </td><td align="center" rowspan="1" colspan="1">9.62 </td></tr><tr><td align="left" rowspan="1" colspan="1">sphingosine-1-phosphate lyase 1</td><td align="left" rowspan="1" colspan="1"><italic>SGPL1</italic></td><td align="center" rowspan="1" colspan="1">1.06 </td><td align="center" rowspan="1" colspan="1">5.90 </td></tr><tr><td align="left" rowspan="1" colspan="1">3’-phosphoadenosine 5’-phosphosulfate synthase 2</td><td align="left" rowspan="1" colspan="1"><italic>PAPSS2</italic></td><td align="center" rowspan="1" colspan="1">1.05 </td><td align="center" rowspan="1" colspan="1">5.47 </td></tr><tr><td align="left" rowspan="1" colspan="1">fibronectin 1</td><td align="left" rowspan="1" colspan="1"><italic>FN1</italic></td><td align="center" rowspan="1" colspan="1">0.95 </td><td align="center" rowspan="1" colspan="1">5.84 </td></tr><tr><td align="left" rowspan="1" colspan="1">coagulation factor XIII, A1 polypeptide</td><td align="left" rowspan="1" colspan="1"><italic>F13A1</italic></td><td align="center" rowspan="1" colspan="1">–1.33 </td><td align="center" rowspan="1" colspan="1">–12.62 </td></tr><tr><td align="left" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" colspan="3" rowspan="1">Constitutively responding genes</td><td align="center" rowspan="1" colspan="1">0–4 hr</td><td align="center" rowspan="1" colspan="1">4–24 hr</td></tr><tr><td align="left" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" colspan="3" rowspan="1"> Cytokine</td><td align="center" rowspan="1" colspan="1">&gt; 4.0</td><td align="center" rowspan="1" colspan="1">&gt; 4.0</td></tr><tr><td align="left" rowspan="4" colspan="1"/><td align="left" rowspan="1" colspan="1">interleukin 1, beta</td><td align="left" rowspan="1" colspan="1"><italic>IL1B</italic></td><td align="center" rowspan="1" colspan="1">26.00 </td><td align="center" rowspan="1" colspan="1">4.09 </td></tr><tr><td align="left" rowspan="1" colspan="1">interleukin 8</td><td align="left" rowspan="1" colspan="1"><italic>IL8</italic></td><td align="center" rowspan="1" colspan="1">16.28 </td><td align="center" rowspan="1" colspan="1">4.84 </td></tr><tr><td align="left" rowspan="1" colspan="1">interleukin 1, alpha</td><td align="left" rowspan="1" colspan="1"><italic>IL1A</italic></td><td align="center" rowspan="1" colspan="1">4.32 </td><td align="center" rowspan="1" colspan="1">16.48 </td></tr><tr><td align="left" rowspan="1" colspan="1">Epstein-Barr virus induced 3</td><td align="left" rowspan="1" colspan="1"><italic>EBI3</italic></td><td align="center" rowspan="1" colspan="1">6.64 </td><td align="center" rowspan="1" colspan="1">7.44 </td></tr><tr><td align="left" colspan="5" rowspan="1"> Enzyme</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">indoleamine 2,3-dioxygenase 1</td><td align="left" rowspan="1" colspan="1"><italic>IDO1</italic></td><td align="center" rowspan="1" colspan="1">5.67 </td><td align="center" rowspan="1" colspan="1">30.67 </td></tr></tbody></table><table-wrap-foot><p>Early responding genes were those altered at 4 hr; slowly responding genes were those altered at 24 hr.</p></table-wrap-foot></table-wrap> as “early responding genes”. Among these genes, 6 categorized as “cytokine” were markedly upregulated after 4 hr of
treatment but were moderately upregulated after 24 hr of treatment. Moreover, 2 genes in the “transmembrane receptor” category, 2,
2 genes in the “enzyme” category and 5 genes in the “transcription regulator” category were upregulated in THP-1 cells by L-92
treatment at 4 hr of treatment but showed moderate upregulation at 24 hr of treatment (<xref rid="tbl_002" ref-type="table">Table
2</xref>). In contrast, genes that showed less than a 4-fold change after 4 hr, but over a 4-fold increase in expression after
24 hr of treatment compared with that after 4 hr were categorized as “slowly responding genes” (<xref rid="tbl_002" ref-type="table">Table 2</xref>). Among these genes, 9 categorized as “transmembranes” were markedly upregulated after 24 hr but
showed mild changes after 4 hr of treatment. Moreover, 6 genes in the “cytokine” category and 6 genes in “transcription regulator”
category also showed a significant increase after 24 hr but only mild changes after 4 hr of treatment with L-92 (<xref rid="tbl_002" ref-type="table">Table 2</xref>). Finally, four genes categorized as “cytokine” and 1 gene categorized as an
“enzyme” were constitutively expressed after 4 and 24 hr of treatment (“constitutively responding genes” in <xref rid="tbl_002" ref-type="table">Table 2</xref>). These results suggest that L-92 treatment in THP-1 cells might cause a rapid change in
expression among genes in the “cytokine” category after 4 hr of treatment and subsequently among genes involved in cell signaling
categorized here as “transmembrane receptors” and “cytokine” (<xref rid="tbl_002" ref-type="table">Table 2</xref>). For these cell
responses, the activation of “transcription regulator” genes observed in the early and late phases of responses seems to be
important for subsequent gene expression.</p>
      </sec>
      <sec>
        <title>Quantitative analysis of the gene expressions in THP-1 cells</title>
        <p>To validate the gene expression changes observed in THP-1 cells in response to L-92 cell treatment (<xref rid="tbl_002" ref-type="table">Table 2</xref>), qRT-PCR analysis was performed for 6 randomly selected genes with specific primer pairs:
<italic>TNF</italic> (early responding genes), <italic>CRLF2, CD86 and STAT4</italic> (slowly responding genes); and
<italic>IL8</italic> and <italic>IDO1 </italic>(constitutively responding genes). As shown in <xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p> Changes in gene expressions from 0 to 4 hr (black bar) and 4 to 24 hr (white bar) observed in THP-1 cells after treatment
with L-92 cells as shown by qRT-PCR analysis. The dotted line represents a 4-fold change in expression. The mean ± SD levels
of expression of differentially expressed genes and statistical significance of each gene’s expression between 0 and 4 hr
(black) and 4 and 24 hr (white) are shown. *p&lt;0.05; **p&lt;0.01 (determined by Student’s t-test).</p></caption><graphic xlink:href="bmfh-33-157-g001"/></fig>, statistical changes were confirmed for most of the quantified gene expressions in L-92-treated THP-1 cells. The
<italic>TNF</italic> gene categorized as an early responding gene was significantly upregulated at 4 hr after treatment (black)
but not at 24 hr after treatment (white) (<xref ref-type="fig" rid="fig_001">Fig. 1</xref>). In contrast, in the genes categorized
as slowly responding genes, <italic>CRLF2, CD86</italic> and <italic>STAT4</italic>, the change in expression of each upregulated
gene was bigger at 24 hr (white) than that at 4 hr (black) after treatment (<xref ref-type="fig" rid="fig_001">Fig. 1</xref>).
Genes categorized as constitutively responding genes, <italic>IL8</italic> and <italic>IDO1,</italic> were upregulated both at 4
hr and 24hr (<xref ref-type="fig" rid="fig_001">Fig. 1</xref>). As shown in <xref ref-type="fig" rid="fig_001">Fig. 1</xref>, the
gene expressions randomly quantified by qRT-PCR in THP-1 cells after L-92 treatment showed changes similar to those quantified by
microarray analysis (<xref rid="tbl_002" ref-type="table">Table 2</xref>).</p>
      </sec>
      <sec>
        <title>Highlighted responses in THP-1 cells</title>
        <p>These cell responses at 4 hr and 24 hr are illustrated in <xref ref-type="fig" rid="fig_002">Fig. 2</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p> Changes in gene expression in THP-1 cells after 4 hr of treatment with <italic>Lactobacillus acidophilus</italic> L-92
cells. Genes that were significantly upregulated by L-92 treatment were categorized by the IPA method as described in the
Materials and Methods. Upregulated genes are indicated by red arrows. Black thin arrows represent the predicted flow of the
pathway. Genes grouped by KEGG analysis are indicated by the red dotted line.</p></caption><graphic xlink:href="bmfh-33-157-g002"/></fig> as the early response and in <xref ref-type="fig" rid="fig_003">Fig. 3</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p> Changes in gene expression in THP-1 cells after 24 hr of treatment with <italic>Lactobacillus acidophilus</italic> L-92
cells. Genes that were significantly upregulated genes by L-92 treatment were categorized by the IPA method as described in
the Materials and Methods. Upregulated genes are indicated by red arrows. Black thin arrows represent the predicted flow of
the pathway. Genes grouped by KEGG analysis are indicated by the red dotted line.</p></caption><graphic xlink:href="bmfh-33-157-g003"/></fig> as the slow response. As summarized in <xref ref-type="fig" rid="fig_002">Fig. 2</xref>, in the early phase of the cellular
response (4 hr of treatment), various transcription regulator genes, such as <italic>JUN</italic>, <italic>NFkB1</italic>,
<italic>NFkB2</italic>, <italic>HIVEP2</italic> and <italic>RELB,</italic> as well as genes encoding chemokines and cytokines,
such as <italic>CXCL11, CCL4,, CCL3, IL1B, IL8</italic> and <italic>TNF,</italic> were upregulated by L-92 treatment. Two
transmembrane receptor genes, <italic>TLR7</italic> and <italic>ICAM1</italic>, were also upregulated at the early phase of the
treatment (<xref ref-type="fig" rid="fig_002">Fig. 2</xref>). Moreover, the <italic>NOD2</italic> and <italic>MyD88</italic>
genes, which were not involved in the hematological processes in the shown in <xref rid="tbl_002" ref-type="table">Table 2</xref>,
were selected as important genes in the MAPK signal pathway and NOD-like receptor signal pathway by KEGG pathway analysis, with
2.99- fold and 1.25-fold upregulated gene expressions at 4 hr (p&lt;0.05 and p&lt;0.05, respectively) in response to L-92
treatment (<xref ref-type="fig" rid="fig_002">Fig. 2</xref>). During the slow response of the THP-1 cells (24 hr of treatment),
mainly transmembrane receptors, such as <italic>IL2RA, IL7R, CD80, CRLF2, CD86, CD5, HLA-DQA1, IL15RA</italic> and
<italic>CSF2RA</italic>, were activated (<xref ref-type="fig" rid="fig_003">Fig. 3</xref>). Some cytokine genes, namely
<italic>IL6, IL23A</italic> and <italic>CCL22</italic>, were also significantly upregulated.</p>
        <p>As listed in <xref rid="tbl_002" ref-type="table">Table 2</xref> and <xref ref-type="fig" rid="fig_002">Figs. 2</xref> and<xref ref-type="fig" rid="fig_003"> 3</xref>, in the early phase of the response in THP-1 cells, mainly transcription regulator genes
and cytokines/chemokines were activated. Subsequently, many transmembrane receptor genes were mainly upregulated in THP-1 cells in
the late phase of treatment.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s4">
      <title>DISCUSSION</title>
      <p>Increases in some Th1-type cytokines and chemokines have been observed in previous <italic>in vitro</italic> and <italic>in
vivo</italic> studies with L-92 [<xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r13" ref-type="bibr">13</xref>], although
those studies did not include detailed analyses of the underlying mechanisms. In the present study, we first investigated the
immunomodulatory responses that occurred in THP-1 cells as a model of APCs in response to probiotic L-92 cell exposure by using
microarray analysis for a detailed understanding of the host gastrointestinal immune response. As expected from a previous study
showing the probiotic anti-allergy effects of L-92 <italic>in vivo</italic>, many Th1-type cytokines and chemokines that would be
expected to increase during anti-allergic and anti-inflammatory events were elevated in THP-1 cells treated with L-92 in the present
study, as summarized in <xref ref-type="fig" rid="fig_002">Figs. 2</xref> and<xref ref-type="fig" rid="fig_003"> 3</xref>. The THP-1
response in the early phase involved mainly the activation of transcription regulator genes and cytokine/chemokine genes categorized
as the MAPK signaling pathway and the NOD-like receptor signaling pathway (<xref ref-type="fig" rid="fig_002">Fig. 2</xref>).
Subsequently, many transmembrane receptor and transcription regulator genes in the Toll-like receptor signaling pathway were
upregulated in the late phase of the treatment (<xref ref-type="fig" rid="fig_003">Fig. 3</xref>). Taking into account the above
results, the transcriptional upregulation observed in THP-1 cells co-cultured with L-92 seems to well explain the previous
<italic>in vivo</italic> immunomodulatory effects of L-92 treatment [<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r15" ref-type="bibr">15</xref>].</p>
      <p>Regarding the activation of the Th1-type immune response by L-92 in THP-1 cells, one of the first events would be the induction of
transcription regulator genes involved in TLR-7 signaling; this would trigger the release of some of Th1-type cytokines and
inflammatory cytokines in the MAPK signaling pathway (<xref ref-type="fig" rid="fig_002">Fig. 2</xref>). These molecules, together
with the upregulation of surface markers involved in the maturation of APCs such as <italic>CD86, CD80</italic> and
<italic>CD40</italic>, stimulate the activation of Th1 cells [<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r23" ref-type="bibr">23</xref>]. These changes in gene expression observed in THP-1 cells strongly suggest that the <italic>in vivo</italic>
anti-allergy effect of L-92 might be linked to a Th1-type host response in a phase-dependent manner in the gastrointestinal immune
system.</p>
      <p>Considering the constitutive upregulation of the indoleamine 2,3-dioxygenase (<italic>IDO</italic>) gene observed in the present
study (<xref rid="tbl_002" ref-type="table">Table 2</xref>), other upregulated genes encoding cytokines, such as <italic>IL8, TNF,
IL1B</italic> and <italic>IL12</italic>, seem to be closely linked to IDO enhancement. IDO has been identified as a key enzyme
with immunomodulatory effects, resulting from its enzymatic activity that leads to catabolism of the essential amino acid
L-tryptophane [<xref rid="r24" ref-type="bibr">24</xref>, <xref rid="r25" ref-type="bibr">25</xref>]. This enzyme is expressed in
epithelial cells, macrophages, and DCs induced by proinflammatory cytokines, including type I and type II IFN [<xref rid="r26" ref-type="bibr">26</xref>]. Recent studies suggested the involvement of IL-1β, TNF-α and IL-12 in the induction of IDO in DCs [<xref rid="r27" ref-type="bibr">27</xref>, <xref rid="r28" ref-type="bibr">28</xref>] and engagement of CTLA-4 with CD80/CD86 on the
membrane of DCs in the stimulation of IDO transcriptional expression and activity [<xref rid="r29" ref-type="bibr">29</xref>, <xref rid="r30" ref-type="bibr">30</xref>]. These observations suggest that the upregulation of CD80 and CD86 on the membrane of APCs
caused by treatment with L-92 might be closely linked to activation of the <italic>IDO</italic> gene. IDO1 is known to induce
regulatory T cells (Tregs) [<xref rid="r31" ref-type="bibr">31</xref>, <xref rid="r32" ref-type="bibr">32</xref>] and to inhibit
T-cell proliferation and promote T-cell apoptosis by degradation of L-tryptophan to convert into toxic metabolites such as
quinolinic acid and 3-hydroxy-anthranilic acid [<xref rid="r31" ref-type="bibr">31</xref>, <xref rid="r33" ref-type="bibr">33</xref>].</p>
      <p>In conclusion, key molecules are induced in cultured THP-1 cells by L-92 stimulation that are suggested to play a central role in
skewing toward Th1 cells and also in inducing T cell suppression networks. The present study on cultured THP-1 cell opens the way
for understanding the immunomodulatory networks modulated by L-92 in the gastrointestinal immune system <italic>in vivo</italic>.
The primary information on both gene profiling and the key genes altered in THP-1 cells after L-92 exposure obtained in the present
study will be very important for a detailed understanding of the strain-dependent immune responses to other
<italic>Lactobacillus</italic> species in future studies.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>This study was supported in part by Grants-in-Aid for Scientific research (A) (H.O.) and Scientific Research on Innovative Areas
(H.O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Gabryszewski</surname><given-names>SJ</given-names></name><name><surname>Bachar</surname><given-names>O</given-names></name><name><surname>Dyer</surname><given-names>KD</given-names></name><name><surname>Percopo</surname><given-names>CM</given-names></name><name><surname>Killoran</surname><given-names>KE</given-names></name><name><surname>Domachowske</surname><given-names>JB</given-names></name><name><surname>Rosenberg</surname><given-names>HF</given-names></name><name><surname>Rosenberg</surname><given-names>FH</given-names></name></person-group>
<year>2011</year>
<article-title><italic>Lactobacillus</italic>-mediated priming of the respiratory mucosa
protects against lethal <italic>pneumovirus</italic> infection</article-title>. <source>J Immunol</source><volume>186</volume>:
<fpage>1151</fpage>–<lpage>1161</lpage>. <pub-id pub-id-type="pmid">21169550</pub-id></mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Youn</surname><given-names>HN</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Lee</surname><given-names>YN</given-names></name><name><surname>Park</surname><given-names>JK</given-names></name><name><surname>Yuk</surname><given-names>SS</given-names></name><name><surname>Yang</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Woo</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>HM</given-names></name><name><surname>Lee</surname><given-names>JB</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Choi</surname><given-names>IS</given-names></name><name><surname>Song</surname><given-names>CS</given-names></name></person-group>
<year>2012</year>
<article-title>Intranasal administration of live <italic>Lactobacillus</italic> species
facilitates protection against influenza virus infection in mice</article-title>. <source>Antiviral
Res</source><volume>93</volume>: <fpage>138</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="pmid">22120759</pub-id></mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Mack</surname><given-names>DR</given-names></name></person-group>
<year>2011</year>
<article-title>Probiotics in inflammatory bowel diseases and associated
conditions</article-title>. <source>Nutrients</source><volume>3</volume>: <fpage>245</fpage>–<lpage>264</lpage>.
<pub-id pub-id-type="pmid">22254095</pub-id></mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Borchers</surname><given-names>AT</given-names></name><name><surname>Selmi</surname><given-names>C</given-names></name><name><surname>Meyers</surname><given-names>FJ</given-names></name><name><surname>Keen</surname><given-names>CL</given-names></name><name><surname>Gershwin</surname><given-names>ME</given-names></name></person-group>
<year>2009</year>
<article-title>Probiotics and immunity</article-title>. <source>J
Gastroenterol</source><volume>44</volume>: <fpage>26</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="pmid">19159071</pub-id></mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Fink</surname><given-names>LN</given-names></name><name><surname>Zeuthen</surname><given-names>LH</given-names></name><name><surname>Christensen</surname><given-names>HR</given-names></name><name><surname>Morandi</surname><given-names>B</given-names></name><name><surname>Frøkiaer</surname><given-names>H</given-names></name><name><surname>Ferlazzo</surname><given-names>G</given-names></name></person-group>
<year>2007</year>
<article-title>Distinct gut-derived lactic acid bacteria elicit divergent dendritic
cell-mediated NK cell responses</article-title>. <source>Int Immunol</source><volume>19</volume>:
<fpage>1319</fpage>–<lpage>1327</lpage>. <pub-id pub-id-type="pmid">17951600</pub-id></mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Zeuthen</surname><given-names>LH</given-names></name><name><surname>Christensen</surname><given-names>HR</given-names></name><name><surname>Frøkiaer</surname><given-names>H</given-names></name></person-group>
<year>2006</year>
<article-title>Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor
alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with
gram-negative bacteria</article-title>. <source>Clin Vaccine Immunol</source><volume>13</volume>:
<fpage>365</fpage>–<lpage>375</lpage>. <pub-id pub-id-type="pmid">16522779</pub-id></mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Ishida</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>F</given-names></name><name><surname>Kanzato</surname><given-names>H</given-names></name><name><surname>Sawada</surname><given-names>D</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name><name><surname>Kagata</surname><given-names>H</given-names></name><name><surname>Oh-Ida</surname><given-names>M</given-names></name><name><surname>Takeuchi</surname><given-names>H</given-names></name><name><surname>Fujiwara</surname><given-names>S</given-names></name></person-group>
<year>2005</year>
<article-title>Effect of milk fermented with <italic>Lactobacillus acidophilus</italic> strain
L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial</article-title>. <source>Biosci
Biotechnol Biochem</source><volume>69</volume>: <fpage>1652</fpage>–<lpage>1660</lpage>. <pub-id pub-id-type="pmid">16195581</pub-id></mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Ishida</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>F</given-names></name><name><surname>Kanzato</surname><given-names>H</given-names></name><name><surname>Sawada</surname><given-names>D</given-names></name><name><surname>Hirata</surname><given-names>H</given-names></name><name><surname>Nishimura</surname><given-names>A</given-names></name><name><surname>Kajimoto</surname><given-names>O</given-names></name><name><surname>Fujiwara</surname><given-names>S</given-names></name></person-group>
<year>2005</year>
<article-title>Clinical effects of <italic>Lactobacillus acidophilus</italic> strain L-92 on
perennial allergic rhinitis: a double-blind, placebo-controlled study</article-title>. <source>J Dairy
Sci</source><volume>88</volume>: <fpage>527</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="pmid">15653517</pub-id></mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Shah</surname><given-names>MM</given-names></name><name><surname>Miyamoto</surname><given-names>Y</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Yamashita</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Ezaki</surname><given-names>T</given-names></name><name><surname>Nagai</surname><given-names>H</given-names></name><name><surname>Inagaki</surname><given-names>N</given-names></name></person-group>
<year>2010</year>
<article-title>Orally supplemented <italic>Lactobacillus acidophilus</italic> strain L-92
inhibits passive and active cutaneous anaphylaxis as well as 2,4-dinitroflurobenzene and mite fecal antigen induced atopic
dermatitis-like skin lesions in mice</article-title>. <source>Microbiol Immunol</source><volume>54</volume>:
<fpage>523</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="pmid">20840151</pub-id></mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Torii</surname><given-names>S</given-names></name><name><surname>Torii</surname><given-names>A</given-names></name><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Urisu</surname><given-names>A</given-names></name><name><surname>Terada</surname><given-names>A</given-names></name><name><surname>Fujisawa</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Ishida</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>F</given-names></name><name><surname>Kanzato</surname><given-names>H</given-names></name><name><surname>Sawada</surname><given-names>D</given-names></name><name><surname>Nonaka</surname><given-names>A</given-names></name><name><surname>Hatanaka</surname><given-names>M</given-names></name><name><surname>Fujiwara</surname><given-names>S</given-names></name></person-group>
<year>2011</year>
<article-title>Effects of oral administration of <italic>Lactobacillus acidophilus</italic>
L-92 on the symptoms and serum markers of atopic dermatitis in children</article-title>. <source>Int Arch Allergy
Immunol</source><volume>154</volume>: <fpage>236</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="pmid">20861645</pub-id></mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Ikeda</surname><given-names>N</given-names></name><name><surname>Kaneko</surname><given-names>K</given-names></name><name><surname>Ejiri</surname><given-names>M</given-names></name><name><surname>Mizutani</surname><given-names>J</given-names></name><name><surname>Ohshima</surname><given-names>K</given-names></name><name><surname>Kajimoto</surname><given-names>O</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name></person-group>
<year>2000</year>
<article-title>Improvement of the constipation of healthy volunteers by uptake of lactic acid
bacteria fermented milk</article-title>. <source>J Nutr Food</source><volume>3</volume>:
<fpage>59</fpage>–<lpage>68</lpage>.</mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kanzato</surname><given-names>H</given-names></name><name><surname>Fujiwara</surname><given-names>S</given-names></name><name><surname>Ise</surname><given-names>W</given-names></name><name><surname>Kaminogawa</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>R</given-names></name><name><surname>Hachimura</surname><given-names>S</given-names></name></person-group>
<year>2008</year>
<article-title><italic>Lactobacillus acidophilus</italic> strain L-92 induces apoptosis of
antigen-stimulated T cells by modulating dendritic cell function</article-title>.
<source>Immunobiology</source><volume>213</volume>: <fpage>399</fpage>–<lpage>408</lpage>. <pub-id pub-id-type="pmid">18472048</pub-id></mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Torii</surname><given-names>A</given-names></name><name><surname>Torii</surname><given-names>S</given-names></name><name><surname>Fujiwara</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Inagaki</surname><given-names>N</given-names></name><name><surname>Nagai</surname><given-names>H</given-names></name></person-group>
<year>2007</year>
<article-title><italic>Lactobacillus acidophilus</italic> strain L-92 regulates the production
of Th1 cytokine as well as Th2 cytokines</article-title>. <source>Allergol Int</source><volume>56</volume>:
<fpage>293</fpage>–<lpage>301</lpage>. <pub-id pub-id-type="pmid">17646735</pub-id></mixed-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Sagitani</surname><given-names>A.</given-names></name></person-group><article-title>Anti-allergic effects of <italic>Lactobacillus acidophilus</italic> L-92 strain</article-title>.
<year>2010</year>
<source>Jpn J Lactic Acid Bact</source><volume>21</volume>: <fpage>1</fpage>–<lpage>7</lpage> (in Japanese).
</mixed-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Ashida</surname><given-names>N</given-names></name><name><surname>Yanagihara</surname><given-names>S</given-names></name><name><surname>Shinoda</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name></person-group>
<year>2011</year>
<article-title>Characterization of adhesive molecule with affinity to Caco-2 cells in
<italic>Lactobacillus acidophilus</italic> by proteome analysis</article-title>. <source>J Biosci
Bioeng</source><volume>112</volume>: <fpage>333</fpage>–<lpage>337</lpage>. <pub-id pub-id-type="pmid">21763196</pub-id></mixed-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Sansonetti</surname><given-names>PJ</given-names></name></person-group>
<year>2004</year>
<article-title>War and peace at mucosal surfaces</article-title>. <source>Nat Rev
Immunol</source><volume>4</volume>: <fpage>953</fpage>–<lpage>964</lpage>. <pub-id pub-id-type="pmid">15573130</pub-id></mixed-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name></person-group>
<year>2004</year>
<article-title>Toll-like receptor signalling</article-title>. <source>Nat Rev
Immunol</source><volume>4</volume>: <fpage>499</fpage>–<lpage>511</lpage>. <pub-id pub-id-type="pmid">15229469</pub-id></mixed-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Weiss</surname><given-names>G</given-names></name><name><surname>Rasmussen</surname><given-names>S</given-names></name><name><surname>Nielsen Fink</surname><given-names>L</given-names></name><name><surname>Jarmer</surname><given-names>H</given-names></name><name><surname>Nøhr Nielsen</surname><given-names>B</given-names></name><name><surname>Frøkiaer</surname><given-names>H</given-names></name></person-group>
<year>2010</year>
<article-title><italic>Bifidobacterium bifidum</italic> actively changes the gene expression
profile induced by <italic>Lactobacillus acidophilus</italic> in murine dendritic cells</article-title>. <source>PLoS
ONE</source><volume>5</volume>: <fpage>e11065</fpage>. <pub-id pub-id-type="pmid">20548777</pub-id></mixed-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Weiss</surname><given-names>G</given-names></name><name><surname>Rasmussen</surname><given-names>S</given-names></name><name><surname>Zeuthen</surname><given-names>LH</given-names></name><name><surname>Nielsen</surname><given-names>BN</given-names></name><name><surname>Jarmer</surname><given-names>H</given-names></name><name><surname>Jespersen</surname><given-names>L</given-names></name><name><surname>Frøkiaer</surname><given-names>H</given-names></name></person-group>
<year>2010</year>
<article-title><italic>Lactobacillus acidophilus</italic> induces virus immune defence genes
in murine dendritic cells by a Toll-like receptor-2-dependent mechanism</article-title>.
<source>Immunology</source><volume>131</volume>: <fpage>268</fpage>–<lpage>281</lpage>. <pub-id pub-id-type="pmid">20545783</pub-id></mixed-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Meijerink</surname><given-names>M</given-names></name><name><surname>van Hemert</surname><given-names>S</given-names></name><name><surname>Taverne</surname><given-names>N</given-names></name><name><surname>Wels</surname><given-names>M</given-names></name><name><surname>de Vos</surname><given-names>P</given-names></name><name><surname>Bron</surname><given-names>PA</given-names></name><name><surname>Savelkoul</surname><given-names>HF</given-names></name><name><surname>van Bilsen</surname><given-names>J</given-names></name><name><surname>Kleerebezem</surname><given-names>M</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name></person-group>
<year>2010</year>
<article-title>Identification of genetic loci in <italic>Lactobacillus plantarum</italic> that
modulate the immune response of dendritic cells using comparative genome hybridization</article-title>. <source>PLoS
ONE</source><volume>5</volume>: <fpage>e10632</fpage>. <pub-id pub-id-type="pmid">20498715</pub-id></mixed-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>HG</given-names></name><name><surname>Gim</surname><given-names>MG</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Hwang</surname><given-names>HJ</given-names></name><name><surname>Ham</surname><given-names>MS</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Hartung</surname><given-names>T</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Han</surname><given-names>SH</given-names></name><name><surname>Chung</surname><given-names>DK</given-names></name></person-group>
<year>2007</year>
<article-title>Lipoteichoic acid from <italic>Lactobacillus plantarum</italic> elicits both
the production of interleukin-23p19 and suppression of pathogen-mediated interleukin-10 in THP-1 cells</article-title>.
<source>FEMS Immunol Med Microbiol</source><volume>49</volume>: <fpage>205</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="pmid">17328754</pub-id></mixed-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Jin</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Fang</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>N</given-names></name></person-group>
<year>2012</year>
<article-title>Multiple signaling pathways are involved in the interleukine-4 regulated
expression of DC-SIGN in THP-1 cell line</article-title>. <source>J Biomed Biotechnol</source><volume>2012</volume>:
<fpage>357060</fpage>. <pub-id pub-id-type="pmid">22675249</pub-id></mixed-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>QL</given-names></name><name><surname>Feng</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name><name><surname>Li</surname><given-names>XY</given-names></name><name><surname>Zuo</surname><given-names>JP</given-names></name></person-group>
<year>2005</year>
<article-title>Triptolide suppresses CD80 and CD86 expressions and IL-12 production in THP-1
cells</article-title>. <source>Acta Pharmacol Sin</source><volume>26</volume>: <fpage>223</fpage>–<lpage>227</lpage>.
<pub-id pub-id-type="pmid">15663903</pub-id></mixed-citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Munn</surname><given-names>DH</given-names></name><name><surname>Shafizadeh</surname><given-names>E</given-names></name><name><surname>Attwood</surname><given-names>JT</given-names></name><name><surname>Bondarev</surname><given-names>I</given-names></name><name><surname>Pashine</surname><given-names>A</given-names></name><name><surname>Mellor</surname><given-names>AL</given-names></name></person-group>
<year>1999</year>
<article-title>Inhibition of T cell proliferation by macrophage tryptophan
catabolism</article-title>. <source>J Exp Med</source><volume>189</volume>: <fpage>1363</fpage>–<lpage>1372</lpage>.
<pub-id pub-id-type="pmid">10224276</pub-id></mixed-citation>
      </ref>
      <ref id="r25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Mellor</surname><given-names>AL</given-names></name><name><surname>Munn</surname><given-names>DH</given-names></name></person-group>
<year>1999</year>
<article-title>Tryptophan catabolism and T-cell tolerance: immunosuppression by
starvation?</article-title><source>Immunol Today</source><volume>20</volume>: <fpage>469</fpage>–<lpage>473</lpage>.
<pub-id pub-id-type="pmid">10500295</pub-id></mixed-citation>
      </ref>
      <ref id="r26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Taylor</surname><given-names>MW</given-names></name><name><surname>Feng</surname><given-names>GS</given-names></name></person-group>
<year>1991</year>
<article-title>Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and
tryptophan catabolism</article-title>. <source>FASEB J</source><volume>5</volume>: <fpage>2516</fpage>–<lpage>2522</lpage>.
<pub-id pub-id-type="pmid">1907934</pub-id></mixed-citation>
      </ref>
      <ref id="r27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Robinson</surname><given-names>CM</given-names></name><name><surname>Shirey</surname><given-names>KA</given-names></name><name><surname>Carlin</surname><given-names>JM</given-names></name></person-group>
<year>2003</year>
<article-title>Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma
and tumor necrosis factor-alpha</article-title>. <source>J Interferon Cytokine Res</source><volume>23</volume>:
<fpage>413</fpage>–<lpage>421</lpage>. <pub-id pub-id-type="pmid">13678429</pub-id></mixed-citation>
      </ref>
      <ref id="r28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Robinson</surname><given-names>CM</given-names></name><name><surname>Hale</surname><given-names>PT</given-names></name><name><surname>Carlin</surname><given-names>JM</given-names></name></person-group>
<year>2005</year>
<article-title>The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the
synergistic induction of indoleamine dioxygenase</article-title>. <source>J Interferon Cytokine Res</source><volume>25</volume>:
<fpage>20</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="pmid">15684619</pub-id></mixed-citation>
      </ref>
      <ref id="r29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Fallarino</surname><given-names>F</given-names></name><name><surname>Grohmann</surname><given-names>U</given-names></name><name><surname>Hwang</surname><given-names>KW</given-names></name><name><surname>Orabona</surname><given-names>C</given-names></name><name><surname>Vacca</surname><given-names>C</given-names></name><name><surname>Bianchi</surname><given-names>R</given-names></name><name><surname>Belladonna</surname><given-names>ML</given-names></name><name><surname>Fioretti</surname><given-names>MC</given-names></name><name><surname>Alegre</surname><given-names>ML</given-names></name><name><surname>Puccetti</surname><given-names>P</given-names></name></person-group>
<year>2003</year>
<article-title>Modulation of tryptophan catabolism by regulatory T cells</article-title>.
<source>Nat Immunol</source><volume>4</volume>: <fpage>1206</fpage>–<lpage>1212</lpage>. <pub-id pub-id-type="pmid">14578884</pub-id></mixed-citation>
      </ref>
      <ref id="r30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Fallarino</surname><given-names>F</given-names></name><name><surname>Bianchi</surname><given-names>R</given-names></name><name><surname>Orabona</surname><given-names>C</given-names></name><name><surname>Vacca</surname><given-names>C</given-names></name><name><surname>Belladonna</surname><given-names>ML</given-names></name><name><surname>Fioretti</surname><given-names>MC</given-names></name><name><surname>Serreze</surname><given-names>DV</given-names></name><name><surname>Grohmann</surname><given-names>U</given-names></name><name><surname>Puccetti</surname><given-names>P</given-names></name></person-group>
<year>2004</year>
<article-title>CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells
from oxidative stress in nonobese diabetic mice</article-title>. <source>J Exp Med</source><volume>200</volume>:
<fpage>1051</fpage>–<lpage>1062</lpage>. <pub-id pub-id-type="pmid">15492127</pub-id></mixed-citation>
      </ref>
      <ref id="r31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Mellor</surname><given-names>AL</given-names></name><name><surname>Munn</surname><given-names>DH</given-names></name></person-group>
<year>2008</year>
<article-title>Creating immune privilege: active local suppression that benefits friends, but
protects foes</article-title>. <source>Nat Rev Immunol</source><volume>8</volume>: <fpage>74</fpage>–<lpage>80</lpage>.
<pub-id pub-id-type="pmid">18064049</pub-id></mixed-citation>
      </ref>
      <ref id="r32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Matteoli</surname><given-names>G</given-names></name><name><surname>Mazzini</surname><given-names>E</given-names></name><name><surname>Iliev</surname><given-names>ID</given-names></name><name><surname>Mileti</surname><given-names>E</given-names></name><name><surname>Fallarino</surname><given-names>F</given-names></name><name><surname>Puccetti</surname><given-names>P</given-names></name><name><surname>Chieppa</surname><given-names>M</given-names></name><name><surname>Rescigno</surname><given-names>M</given-names></name></person-group>
<year>2010</year>
<article-title>Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences
T regulatory/T effector cell balance and oral tolerance induction</article-title>. <source>Gut</source><volume>59</volume>:
<fpage>595</fpage>–<lpage>604</lpage>. <pub-id pub-id-type="pmid">20427394</pub-id></mixed-citation>
      </ref>
      <ref id="r33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Fallarino</surname><given-names>F</given-names></name><name><surname>Grohmann</surname><given-names>U</given-names></name><name><surname>Vacca</surname><given-names>C</given-names></name><name><surname>Bianchi</surname><given-names>R</given-names></name><name><surname>Orabona</surname><given-names>C</given-names></name><name><surname>Spreca</surname><given-names>A</given-names></name><name><surname>Fioretti</surname><given-names>MC</given-names></name><name><surname>Puccetti</surname><given-names>P</given-names></name></person-group>
<year>2002</year>
<article-title>T cell apoptosis by tryptophan catabolism</article-title>. <source>Cell Death
Differ</source><volume>9</volume>: <fpage>1069</fpage>–<lpage>1077</lpage>. <pub-id pub-id-type="pmid">12232795</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata><about xmlns=""><provenance xmlns="http://www.openarchives.org/OAI/2.0/provenance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/provenance http://www.openarchives.org/OAI/2.0/provenance.xsd"><originDescription harvestDate="2018-06-11T22:13:09.769Z" altered="true"><baseURL>https://www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</baseURL><identifier>oai:pubmedcentral.nih.gov:4219982</identifier><datestamp>2014-11-06</datestamp><metadataNamespace/></originDescription></provenance><oaf:datainfo><oaf:inferred>false</oaf:inferred><oaf:deletedbyinference>false</oaf:deletedbyinference><oaf:trust>0.9</oaf:trust><oaf:inferenceprovenance/><oaf:provenanceaction schemename="dnet:provenanceActions" schemeid="dnet:provenanceActions" classname="sysimport:crosswalk:repository" classid="sysimport:crosswalk:repository"/></oaf:datainfo></about></oai:record>